CFX™ + Therapeutic Stem Cells
Chronic Heart Failure (Remuscularization)
Pre-clinicalActive
Key Facts
Indication
Chronic Heart Failure (Remuscularization)
Phase
Pre-clinical
Status
Active
Company
About Cellular Logistics
Cellular Logistics is a private, preclinical-stage biotech founded in 2017 and based in Madison, Wisconsin. The company has developed CFX™, a first-of-its-kind iPSC-derived biomaterial designed as a therapeutic and delivery matrix for cardiac repair. Its strategy targets both acute myocardial infarction to prevent heart failure and chronic heart failure to restore function, positioning it in the large and underserved cardiovascular regenerative medicine market. The company holds key patents and has recently secured funding for assay development.
View full company profile